Katharina Fritzen1, Kornelia Basinska1,2, Matilde Rubio-Almanza3, Antonio Nicolucci4, Brian Kennon5, Bruno Vergès6, Katerina Zakrzewska7, Oliver Schnell1,8. 1. Sciarc GmbH, Baierbrunn, Germany. 2. Institute of Nursing Science, Faculty of Medicine, University of Basel, Basel, Switzerland. 3. Endocrinology and Nutrition Department Hospital Universitario y Politécnico La Fe and Instituto de Investigación Sanitaria La Fe, Valencia, Spain. 4. Center for Outcomes Research and Clinical Epidemiology (CORESEARCH), Pescara, Italy. 5. FRCP, Diabetes Centre, Queen Elizabeth University Hospital, Glasgow, UK. 6. Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France. 7. LifeScan Europe GmbH, Zug, Switzerland. 8. Forschergruppe Diabetes e.V., Muenchen-Neuherberg, Germany.
Abstract
BACKGROUND: Self-monitoring of blood glucose supported by the diabetes-app OneTouch Reveal® has demonstrated to improve HbA1c. We aimed at analyzing costs savings related the integration of telemedical features into diabetes management. METHODS: Data from a randomized controlled trial were used to assess the 10-year risk of patients for fatal myocardial infarction (MI). On the basis of this risk assessments-also related to a 5% or 10% reduction of hypoglycemic episodes-cost savings for the health care systems of five European countries-France, Germany, Italy, Spain, and the United Kingdom-were modeled. RESULTS:HbA1c reduction of 0.92% in insulin-treated type 2 diabetes patients (T2DM) was associated with a 2.3% decreased 10-year risk for fatal MI. In combination with a 10% reduction of hypoglycemic events this risk reduction led to cost savings of €16.1 million (France), €57.8 million (Germany), €30.9 million (Italy), €23.8 million (Spain), and €5.8 million (UK), considering all insulin-treated T2DM patients in the respective countries. CONCLUSION: Improving metabolic control and thus risk for comorbidities like MI by combining the glucose meter with CRI with telemedical features has the potential to reduce costs for European health care systems.
RCT Entities:
BACKGROUND: Self-monitoring of blood glucose supported by the diabetes-app OneTouch Reveal® has demonstrated to improve HbA1c. We aimed at analyzing costs savings related the integration of telemedical features into diabetes management. METHODS: Data from a randomized controlled trial were used to assess the 10-year risk of patients for fatal myocardial infarction (MI). On the basis of this risk assessments-also related to a 5% or 10% reduction of hypoglycemic episodes-cost savings for the health care systems of five European countries-France, Germany, Italy, Spain, and the United Kingdom-were modeled. RESULTS: HbA1c reduction of 0.92% in insulin-treated type 2 diabetespatients (T2DM) was associated with a 2.3% decreased 10-year risk for fatal MI. In combination with a 10% reduction of hypoglycemic events this risk reduction led to cost savings of €16.1 million (France), €57.8 million (Germany), €30.9 million (Italy), €23.8 million (Spain), and €5.8 million (UK), considering all insulin-treated T2DM patients in the respective countries. CONCLUSION: Improving metabolic control and thus risk for comorbidities like MI by combining the glucose meter with CRI with telemedical features has the potential to reduce costs for European health care systems.
Authors: Graham P Leese; Jixian Wang; Janice Broomhall; Paul Kelly; Andrew Marsden; William Morrison; Brian M Frier; Andrew D Morris Journal: Diabetes Care Date: 2003-04 Impact factor: 19.112
Authors: Andrew Farmer; Elizabeth Balman; Roger Gadsby; Jane Moffatt; Sue Cradock; Lisa McEwen; Kevin Jameson Journal: Curr Med Res Opin Date: 2008-10-02 Impact factor: 2.580
Authors: Allan Wailoo; Steve Goodacre; Fiona Sampson; Mónica Hernández Alava; Christian Asseburg; Stephen Palmer; Mark Sculpher; Keith Abrams; Mark de Belder; Huon Gray Journal: Heart Date: 2009-06-08 Impact factor: 5.994
Authors: Mark D Danese; Michelle Gleeson; Lucie Kutikova; Robert I Griffiths; Ali Azough; Kamlesh Khunti; Sreenivasa Rao Kondapally Seshasai; Kausik K Ray Journal: BMJ Open Date: 2016-08-05 Impact factor: 2.692
Authors: Morgan Hampton Randall; Zachary Merle Haulsee; Jingwen Zhang; Justin Marsden; William Patrick Moran; Elizabeth Barnhardt Kirkland Journal: Int J Med Inform Date: 2020-09-11 Impact factor: 4.046
Authors: Katharina Fritzen; Kornelia Basinska; Constantin Stautner; Karl F Braun; Matilde Rubio-Almanza; Antonio Nicolucci; Brian Kennon; Bruno Vergès; Yasser Hosny; Oliver Schnell Journal: J Diabetes Sci Technol Date: 2019-08-06